Chinese Drugmaker Takes Alzheimer’s ‘Seaweed Drug’ Off the Market
Summary by Being Patient
1 Articles
1 Articles
All
Left
Center
Right
Chinese Drugmaker Takes Alzheimer’s ‘Seaweed Drug’ Off the Market
This controversial, first-of-its-kind, algae-based drug for Alzheimer’s was approved in China. But citing financial concerns, the drugmaker is retiring it for good. Green Valley... The post Chinese Drugmaker Takes Alzheimer’s ‘Seaweed Drug’ Off the Market appeared first on Being Patient.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium